Recent News

• 09.02.2025 - Korro to Participate in Upcoming Investor and Scientific Conferences
• 09.02.2025 - Korro to Participate in Upcoming Investor and Scientific Conferences
• 08.12.2025 - Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 08.12.2025 - Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 07.21.2025 - Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110
• 07.21.2025 - Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110

Recent Filings

• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - 8-K Current report
• 08.12.2025 - EX-99.1 EX-99.1
• 06.18.2025 - 8-K/A Current report
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities